Literature DB >> 31077820

miRNA inhibition by proximity-enabled Dicer inactivation.

Hao Yan1, Fu-Sen Liang2.   

Abstract

microRNAs (miRNAs) are considered as master regulators of biological processes. Dysregulation of miRNA expression has been implicated in many human diseases. Driven by the key biological roles and the therapeutic potential, developing methods for miRNA regulation has become an intense research area. Due to favorable pharmacological properties, small molecule-based miRNA inhibition emerges as a promising strategy and significant progresses have been made. However, it remains challenging to regulate miRNA using small molecules because of the inherent difficulty in RNA targeting and inhibition. Herein we outline the workflow of generating bifunctional small molecule inhibitors blocking miRNA biogenesis through proximity-enabled inactivation of Dicer, an enzyme required for the processing of precursor miRNA (pre-miRNA) into mature miRNA. By conjugating a weak Dicer inhibitor with a pre-miRNA binder, the inhibitor can be delivered to the Dicer processing site associated with the targeted pre-miRNA, and as a result inhibiting Dicer-mediated pre-miRNA processing. This protocol can be applicable in producing bifunctional inhibitors for different miRNAs.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dicer; RNA binder; RNase inhibitor; miRNA inhibition

Mesh:

Substances:

Year:  2019        PMID: 31077820      PMCID: PMC6756959          DOI: 10.1016/j.ymeth.2019.05.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  50 in total

1.  Sequence requirements for micro RNA processing and function in human cells.

Authors:  Yan Zeng; Bryan R Cullen
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

2.  Fluorescence-based high-throughput screening of dicer cleavage activity.

Authors:  Katerina Podolska; David Sedlak; Petr Bartunek; Petr Svoboda
Journal:  J Biomol Screen       Date:  2013-08-14

3.  Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.

Authors:  Duc Duy Vo; Thi Phuong Anh Tran; Cathy Staedel; Rachid Benhida; Fabien Darfeuille; Audrey Di Giorgio; Maria Duca
Journal:  Chemistry       Date:  2016-03-01       Impact factor: 5.236

4.  Identification of small molecules that suppress microRNA function and reverse tumorigenesis.

Authors:  Koichi Watashi; Man Lung Yeung; Matthew F Starost; Ramachandra S Hosmane; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

5.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

6.  Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.

Authors:  Muriel Billamboz; Fabrice Bailly; Maria Letizia Barreca; Laura De Luca; Jean-François Mouscadet; Christina Calmels; Marie-Line Andréola; Myriam Witvrouw; Frauke Christ; Zeger Debyser; Philippe Cotelle
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

7.  Discovering ligands for a microRNA precursor with peptoid microarrays.

Authors:  Sara Chirayil; Rachel Chirayil; Kevin J Luebke
Journal:  Nucleic Acids Res       Date:  2009-06-26       Impact factor: 16.971

8.  Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.

Authors:  Colleen M Connelly; Robert E Boer; Michelle H Moon; Peter Gareiss; John S Schneekloth
Journal:  ACS Chem Biol       Date:  2016-12-23       Impact factor: 5.100

9.  miRBase: annotating high confidence microRNAs using deep sequencing data.

Authors:  Ana Kozomara; Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2013-11-25       Impact factor: 16.971

10.  Expansion of cat-ELCCA for the Discovery of Small Molecule Inhibitors of the Pre-let-7-Lin28 RNA-Protein Interaction.

Authors:  Daniel A Lorenz; Tanpreet Kaur; Samuel A Kerk; Erin E Gallagher; Jorge Sandoval; Amanda L Garner
Journal:  ACS Med Chem Lett       Date:  2018-05-16       Impact factor: 4.345

View more
  5 in total

Review 1.  Affecting RNA biology genome-wide by binding small molecules and chemically induced proximity.

Authors:  Jared T Baisden; Jessica L Childs-Disney; Lucas S Ryan; Matthew D Disney
Journal:  Curr Opin Chem Biol       Date:  2021-06-09       Impact factor: 8.972

Review 2.  Autophagy Regulation by Crosstalk between miRNAs and Ubiquitination System.

Authors:  Junyan Qu; Zhenghong Lin
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

Review 3.  The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside-A Systematic Literature Review.

Authors:  Salvatore Giovanni Vitale; Anna Maria Fulghesu; Mislav Mikuš; Rafał Watrowski; Maurizio Nicola D'Alterio; Li-Te Lin; Mohsin Shah; Enrique Reyes-Muñoz; Thozhukat Sathyapalan; Stefano Angioni
Journal:  Biomedicines       Date:  2022-07-28

4.  Bifunctional small molecule-oligonucleotide hybrid as microRNA inhibitor.

Authors:  Umesh Bhattarai; Wei-Che Hsieh; Hao Yan; Zhi-Fo Guo; Ashif Yasin Shaikh; Aria Soltani; Yabin Song; Danith H Ly; Fu-Sen Liang
Journal:  Bioorg Med Chem       Date:  2020-02-18       Impact factor: 3.461

Review 5.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.